LeMaitre Vascular Inc. (LMAT)
LMAT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1158895/000119312526073360/0001193125-26-073360-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | LMAT on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2006 |
| SEC CIK | 0001158895 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $249.6M |
| Net income | $57.7M |
| Operating income | $67.9M |
| Net margin | 23.1% |
| Operating margin | 27.2% |
| Revenue growth | +13.5% |
| Cash | $28.2M |
| Total assets | $615.7M |
| P/E (computed) | 30.5× |
| P/S (computed) | 7.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $27.5M cash; operating cash flow $19.1M a quarter. | Report 2026-09-30 |
| Shares outstanding | 22,880,871 (2026-11-02); 22,685,994 a year earlier; 22,263,235 three years earlier. | Cover page 2026-11-02 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Grant Thornton LLP, Boston, Massachusetts, United States | PCAOB Form AP 2026-03-10 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $30.0M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $68.0M | $15.0M | $22.0M | $27.5M | $169.3M | $269.4M | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $70.4M | $17.1M | $16.0M | $26.6M | $169.1M | $262.4M | 10-Q 2026-08-05 |
| Q1 2026 2026-03-31 | $66.6M | $15.7M | $15.1M | $26.9M | $168.9M | $256.3M | 10-Q 2026-05-06 |
| Q4 2025 2025-12-31 | $64.5M | $15.6M | $23.2M | $28.2M | $168.6M | $249.6M | 10-K 2026-02-26 |
| Q3 2025 2025-09-30 | $61.0M | $17.4M | $28.8M | $25.5M | $168.4M | $240.9M | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $64.2M | $13.8M | $20.3M | $27.2M | $168.2M | $234.6M | 10-Q 2026-08-05 |
| Q1 2025 2025-03-31 | $59.9M | $11.0M | $9.0M | $25.3M | $168.0M | $226.3M | 10-Q 2026-05-06 |
| Q4 2024 2024-12-31 | $55.7M | $11.2M | $15.2M | $25.6M | $167.8M | $219.9M | 10-K 2026-02-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2021-07-15 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-04 |
| Latest proxy | DEFA14A | 2026-04-14 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.2% |
| 1 month | -4.0% |
| 3 months | -4.4% |
| Year to date | -3.5% |
| 1 year | -12.7% |
| From 52-week high | -33.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| XRAY | DENTSPLY SIRONA Inc. | $8.95 | -2.35% | $1.8B |
| INSP | Inspire Medical Systems Inc. | $59.12 | -3.24% | $1.7B |
| KMTS | Kestra Medical Technologies Ltd. | $27.97 | -2.34% | $1.7B |
| PRCT | PROCEPT BioRobotics Corporation | $23.54 | -1.09% | $1.4B |
| UFPT | UFP Technologies Inc. | $298.54 | -2.14% | $2.3B |
| NVCR | NovoCure Limited | $11.30 | -4.48% | $1.3B |
| TNDM | Tandem Diabetes Care Inc. | $18.48 | -7.92% | $1.3B |
| DRTS | Alpha Tau Medical Ltd. | $11.97 | -10.54% | $1.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier